Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Bone and Mineral Metabolism|September 23, 2011
Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysisToshitaka Nakamura, Mika Tsujimoto, Etsuro Hamaya, et al.
Journal of Bone and Mineral Metabolism|September 23, 2011
Effects of teriparatide in Japanese and non-Japanese populations: bridging findings on pharmacokinetics and efficacyMika Tsujimoto, Kazunori Uenaka, Atsuko Iwata, et al.
Bone|December 21, 2010
PINP as an aid for monitoring patients treated with teriparatideMika Tsujimoto, Peiqi Chen, Akimitsu Miyauchi, et al.
Journal of Cellular Physiology|July 29, 2004
Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interactionMasanori Kanatani, Toshitsugu Sugimoto, Hideaki Sowa, et al.
Journal of Bone and Mineral Metabolism|November 2, 2005
Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cellsMei-Fway Iu, Hiroshi Kaji, Junko Naito, et al.
The Journal of Endocrinology|April 9, 2005
Dexamethasone suppresses Smad3 pathway in osteoblastic cellsMei-Fway Iu, Hiroshi Kaji, Hideaki Sowa, et al.
The Journal of Biological Chemistry|October 1, 2003
Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblastsHideaki Sowa, Hiroshi Kaji, Mei Fway Iu, et al.
The Journal of Biological Chemistry|November 26, 2004
Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunDJunko Naito, Hiroshi Kaji, Hideaki Sowa, et al.
Journal of Bone and Mineral Metabolism|March 29, 2013
Osteoporosis and treatments in Japan: management for preventing subsequent fracturesShuko Nojiri, Russel T Burge, Jennifer A Flynn, et al.
Endocrine Journal|February 6, 2009
Exenatide exhibits dose-dependent effects on glycemic control over 12 weeks in Japanese patients with suboptimally controlled type 2 diabetesTakashi Kadowaki, Mitsuyoshi Namba, Ayuko Yamamura, et al.
Pageof 4